clinical trial · NCT07628881
A Study to Investigate the Relative Bioavailability and Food Effect of Tablet for Oral Suspension of Sonrotoclax in Healthy Adults
BeOne Medicines·phase1·recruiting·n = 12
Healthy VolunteersSonrotoclax Tablet for Oral SuspensionSonrotoclax Tablet
brief summary
The purpose of this study is to evaluate whether blood levels of sonrotoclax after administration of a tablet for oral suspension are similar to those observed with the current sonrotoclax tablet. In addition, this study evaluates the effect of food on the absorption of sonrotoclax after administration of the tablet for oral suspension and the resulting blood levels of sonrotoclax.
started
Jun 17, 2026
primary completion
Sep 27, 2026
completion
Sep 27, 2026
last updated
Jul 9, 2026
official title
A Phase 1, Single-dose, Open-label, Randomized, Crossover Study in Healthy Adult Participants to Evaluate Relative Bioavailability and Food Effect of Tablet for Oral Suspension of Sonrotoclax
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol